# OnCo record cdk46-inhibitor (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/cdk46-inhibitor/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "cdk46-inhibitor" ;
  schema:name "CDK4/6 inhibitors"@en ;
  schema:description "Pills that stop the cell-division engine, added to hormone therapy for the most common type of breast cancer."@en ;
  schema:url <https://onco.cc/technologies/cdk46-inhibitor/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/CDK_inhibitor> ;
  owl:sameAs <http://www.wikidata.org/entity/Q17143494> ;
  schema:citation <https://en.wikipedia.org/wiki/CDK_inhibitor> ;
  onco:status "approved" ;
  onco:related <https://onco.cc/pairings/oral-serd-plus-cdk46-after-esr1/>, <https://onco.cc/pairings/cdk46-plus-endocrine/> ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/hormonal/> ;
  onco:targets <https://onco.cc/targets/cdk4-6/>, <https://onco.cc/targets/estrogen-receptor/> ;
  onco:drugs <https://onco.cc/drugs/palbociclib/>, <https://onco.cc/drugs/ribociclib/>, <https://onco.cc/drugs/abemaciclib/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-sherr-roberts-cdk-inhibitors-genesdev-1999/> .